Thomas N. Konatich

Geen lopende functies

78 jaar

Health Technology

Commercial Services

Consumer Services

Eerdere bekende functies van Thomas N. Konatich

Bedrijven	Functie	Begin	Einde
SIGA TECHNOLOGIES, INC.	Financieel Directeur/CFO	01-04-1998	31-01-2009
	Bedrijfssecretaris	01-04-1998	31-01-2009
	Treasurer	01-04-1998	31-01-2009
Innapharma, Inc. (New York) Innapharma, Inc. (New York) Miscellaneous Commercial ServicesCommercial Services Part of TelMed, Inc., Innapharma, Inc. is a management consulting services company. The company is based in Suffern, NY. Innapharma, Inc. (New York) was acquired by TelMed, Inc. on June 26, 1996.	Financieel Directeur/CFO	01-11-1996	01-03-1998
Seragen, Inc. Seragen, Inc. Pharmaceuticals: MajorHealth Technology Part of Ligand Pharmaceuticals, Inc., Seragen, Inc. develops drugs. The company is based in Westerly, RI. Seragen was acquired by Ligand Pharmaceuticals, Inc. on August 12, 1998 for $57.96 million.	Financieel Directeur/CFO	01-01-1993	01-11-1996

The Trustees of Columbia University in The City of New York

Masters Business Admin

Internationaal

Verenigde Staten

Operationeel

Sectoraal

Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Beursgenoteerde bedrijven	1
SIGA TECHNOLOGIES, INC.	Health Technology

Bedrijven in privébezit	2
Innapharma, Inc. (New York) Innapharma, Inc. (New York) Miscellaneous Commercial ServicesCommercial Services Part of TelMed, Inc., Innapharma, Inc. is a management consulting services company. The company is based in Suffern, NY. Innapharma, Inc. (New York) was acquired by TelMed, Inc. on June 26, 1996.	Commercial Services
Seragen, Inc. Seragen, Inc. Pharmaceuticals: MajorHealth Technology Part of Ligand Pharmaceuticals, Inc., Seragen, Inc. develops drugs. The company is based in Westerly, RI. Seragen was acquired by Ligand Pharmaceuticals, Inc. on August 12, 1998 for $57.96 million.	Health Technology